Patents by Inventor Ralf Labugger

Ralf Labugger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100129851
    Abstract: A method for assessing muscle damage in a biological sample obtained from a subject is disclosed. The method involves obtaining a biological sample from a subject being assessed for muscle damage, and evaluating the sample for the presence or absence of a myofilament protein modification product. Preferably, the myofilament protein modification product is a chemical adduct of a myofilament protein. The method can also be used to assess the extent and/or type of muscle damage in a subject by studying the profile of myofilament protein modification products detected in the sample taken from the subject. The invention further provides a method for screening for an agent which modulates the level of a myofilament protein modification product present in a biological sample or for a calcium sensitizing agent. The invention is applicable to cardiac muscle and skeletal muscle.
    Type: Application
    Filed: July 17, 2009
    Publication date: May 27, 2010
    Inventors: Jennifer E. Van Eyk, Ralf Labugger, Irena Neverova
  • Patent number: 7618782
    Abstract: A method for assessing muscle damage in a biological sample obtained from a subject is disclosed. The method involves obtaining a biological sample from a subject being assessed for muscle damage, and evaluating the sample for the presence or absence of a myofilament protein modification product. Preferably, the myofilament protein modification product is a chemical adduct of a myofilament protein. The method can also be used to assess the extent and/or type of muscle damage in a subject by studying the profile of myofilament protein modification products detected in the sample taken from the subject. The invention further provides a method for screening for an agent which modulates the level of a myofilament protein modification product an present in a biological sample or for a calcium sensitizing agent. The invention is applicable to cardiac muscle and skeletal muscle.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: November 17, 2009
    Assignee: Queen's University at Kingston
    Inventors: Jennifer E. Van Eyk, Ralf Labugger, Irena Neverova
  • Publication number: 20050042681
    Abstract: Protein profiles useful in diagnosing, monitoring, staging, evaluating treatments and treating and selecting treatments for heart failure are provided.
    Type: Application
    Filed: June 25, 2004
    Publication date: February 24, 2005
    Inventors: Jennifer Van Eyk, Brian Stanley, Irena Neverova, Ralf Labugger
  • Publication number: 20020072590
    Abstract: Methods and kits are provided for separating a mixture of proteins in a biological sample. Methods for detecting and profiling proteins in biological samples by the separation method and kits are also provided. These methods are particularly useful in assessing damage to cells such as cardiac and skeletal muscle cells and in the early clinical diagnosis of myocardial damage by detection of myofilament proteins in serum of a subject.
    Type: Application
    Filed: August 21, 2001
    Publication date: June 13, 2002
    Inventors: Jennifer E. Van Eyk, Ralf Labugger, Irena Neverova, David A. Colantonio, Jeremy A. Simpson